<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=iso-8859-1"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all members of PCCN W-W:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>See below the note from PCC wrt a Focus Group Session.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Plse participate if you wish.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Chair PCCN W-W<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=EN-US>Hi all,<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>Thank you for all you’ve been doing over the past several weeks to send out notices to your groups about the focus group sessions that have been taking place throughout the country.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US>Ipsos Reid is still looking for a few people to join tomorrow’s session. Would you please send the info below and the attachment out again to your groups –your extra efforts are very appreciated.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US>Many thanks, Anne<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>Prostate Cancer Canada and The Canadian Partnership Against Cancer are inviting <b>men with living prostate cancer</b> to participate in an on-line/telephone focus group session. This will occur on <b>Thursday, October 23rd</b> (3:30pm PT/ 5:30 pm CDT/ 6:30pm EST/ 7:30 pm ADT). The session will be led by Matt Jones at Ipsos Reid and all names will be kept confidential. Information gathered from the focus groups will be used to help improve services for men living with prostate cancer.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>You will receive a token of appreciation of $75 for your time. Please contact: Matt Jones at Ipsos Reid: 416-572-4479 or Email <a href="mailto:matt.jones@ipsos.com">matt.jones@ipsos.com</a> (Please see attached for more information).<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>Anne Breakey Hart, CVA<br></span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>Manager, PCCN and Volunteer Engagement | Prostate Cancer Canada<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>Gestionnaire,</span><span lang=EN-US style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0067B1'> Mobilisation des bénévoles </span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>| Cancer de la Prostate Canada</span><span lang=EN-US style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0067B1'><o:p></o:p></span></p><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>T </span></b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0070C0'>416-441-2131 ext./poste 229 | <b>E</b></span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0067B1'> </span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#1F497D'><a href="mailto:anne.breakeyhart@prostatecancer.ca">anne.breakeyhart@prostatecancer.ca</a></span><span style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><a href="www.prostatecancer.ca">www.prostatecancer.ca</a><o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><a href="http://www.prostatecancer.ca/"><span style='text-decoration:none'><img border=0 width=277 height=71 id="Picture_x0020_1" src="cid:image001.png@01CFEDEF.4F8D9840" alt=20th-ann></span></a><span style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><a href="http://www.facebook.com/prostatecancercanada"><span style='text-decoration:none'><img border=0 width=24 height=24 id="Picture_x0020_2" src="cid:image002.png@01CFEDEF.4F8D9840" alt=facebook></span></a><span style='color:#1F497D'> </span><a href="http://www.twitter.com/prostatecancerc"><span style='text-decoration:none'><img border=0 width=24 height=24 id="Picture_x0020_3" src="cid:image003.png@01CFEDEF.4F8D9840" alt=twitter></span></a><span style='color:#1F497D'> </span><a href="youtube.com/prostatecancercanada"><span style='text-decoration:none'><img border=0 width=24 height=24 id="Picture_x0020_4" src="cid:image004.png@01CFEDEF.4F8D9840" alt=Youtube></span></a><span style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-family:"Arial","sans-serif";color:#1F497D'>Did you know that the survival rate for prostate cancer can be over 90% when detected early?</span><span style='font-family:"Arial","sans-serif";color:#0067B1'> </span><span style='font-family:"Arial","sans-serif"'><a href="http://prostatecancer.ca/Prostate-Cancer/Testing-and-Diagnosis/The-PSA-Test?lang=en-CA#.VC2ZnRa8ES8">Get checked with a PSA test and know your number.</a></span><span style='font-family:"Arial","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Arial","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-family:"Arial","sans-serif";color:#1F497D'>Saviez-vous que si le cancer de la prostate est dépisté dès ses premiers stades, les chances de survie peuvent dépasser 90 %?</span><span style='font-family:"Arial","sans-serif";color:#0067B1'> </span><span style='font-family:"Arial","sans-serif"'><a href="http://prostatecancer.ca/Prostate-Cancer/Testing-and-Diagnosis/The-PSA-Test?lang=fr-CA"><span lang=FR-CA>Passez un test de l’APS pour connaître votre taux.</span></a><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Arial","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>